Business
Omnicell Reports Fiscal Year and Fourth Quarter 2019 Results
Record annual GAAP and non-GAAP revenues of $897.0 million Record 2019 GAAP net income per diluted share of $1.43 Record 2019 non-GAAP net income per diluted
About this update from Omnicell, Inc.
[{"type":"text","content":"\nRecord annual GAAP and non-GAAP revenues of $897.0 million\n\n\nRecord 2019 GAAP net income per diluted share of $1.43 \n\n\nRecord 2019 non-GAAP net income per diluted share of $2.81\n\n\nRecord ending product backlog of $588 million\n\n MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--\nOmnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its fiscal year and fourth quarter ended December 31, 2019.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200206005931/en/\n\nGAAP Results\n\n\nGAAP revenues for the fourth quarter of 2019 were $248.3 million, up $36.5 million, or 17% from the fourth quarter of 2018. GAAP revenues for the year ended December 31, 2019 were $897.0 million, up $109.7 million, or 14% from the year ended December 31, 2018.\n\n\nFourth quarter 2019 GAAP net income was $22.1 million, or $0.51 per diluted share. This compares to GAAP net income of $14.8 million, or $0.36 per diluted share, for the fourth quarter of 2018.\n\n\nGAAP net income for the year ended December 31, 2019 was $61.3 million, or $1.43 per diluted share. This compares to GAAP net income of $37.7 million, or $0.93 per diluted share, for the year ended December 31, 2018.\n\n\nNon-GAAP Results\n\n\nNon-GAAP revenues for the fourth quarter of 2019 were $248.3 million, up $36.5 million, or 17% from the fourth quarter of 2018. Non-GAAP revenues for the year ended December 31, 2019 were $897.0 million, up $109.7 million, or 14% from the year ended December 31, 2018.\n\n\nNon-GAAP net income for the fourth quarter of 2019 was $33.5 million, or $0.77 per diluted share. This compares to non-GAAP net income of $29.1 million, or $0.70 per diluted share, for the fourth quarter of 2018.\n\n\nNon-GAAP net income for the year ended December 31, 2019 was $120.7 million, or $2.81 per diluted share. This compares to non-GAAP net income of $84.6 million, or $2.09 per diluted share for the year ended December 31, 2018.\n\n\nNon-GAAP net income for each period excludes, when applicable, the effect of share-based compensation expense, amortization expense of acquired intangible assets, acquisition-related expenses, fair value adjustments related to business acquisitions, restructuring and severance...